Nicotine therapeutic benefits: Difference between revisions

*Citation: Jackson, S. E., Brown, J., and Jarvis, M. J. (2021) Dependence on nicotine in US high school students in the context of changing patterns of tobacco product use. Addiction, 116: 1859– 1870. doi: 10.1111/add.15403

*Acknowledgement: Cancer Research UK (C1417/A22962) supported S.J. andJ.B.’s salaries.  

===2020 [https://pubmed.ncbi.nlm.nih.gov/33176942/ Abuse liability assessment of the JUUL system in four flavors relative to combustible cigarette, nicotine gum and a comparator electronic nicotine delivery system among adult smokers]=== <!--T:6-->

<!--T:7-->

*

===2020 [https://www.tandfonline.com/doi/abs/10.1080/10826084.2020.1834582?journalCode=isum20& Dependence and Use Characteristics of Adult JUUL Electronic Cigarette Users]=== <!--T:8-->

<!--T:9-->

*

===2020 [https://pubmed.ncbi.nlm.nih.gov/33086157/ A comparison of product dependence among cigarette only, ENDS only, and dual users: Findings from Wave 3 (2015-2016) of the PATH study]=== <!--T:10-->

<!--T:11-->

*

===2020 [https://onlinelibrary.wiley.com/doi/full/10.1111/add.15060 Dependence on e-cigarettes and cigarettes in a cross-sectional study of US adults]=== <!--T:12-->

<!--T:13-->

*

===2019 [https://pubmed.ncbi.nlm.nih.gov/31375364/ Changes in E-Cigarette Use Behaviors and Dependence in Long-term E-Cigarette Users]=== <!--T:14-->

<!--T:15-->

*

===2018 [https://pubmed.ncbi.nlm.nih.gov/29725702/ Assessment of the abuse liability of three menthol Vuse Solo electronic cigarettes relative to combustible cigarettes and nicotine gum]=== <!--T:16-->

*Citation: Stiles MF, Campbell LR, Jin T, Graff DW, Fant RV, Henningfield JE. Assessment of the abuse liability of three menthol Vuse Solo electronic cigarettes relative to combustible cigarettes and nicotine gum. Psychopharmacology (Berl). 2018 Jul;235(7):2077-2086. doi: 10.1007/s00213-018-4904-x. Epub 2018 May 3. PMID: 29725702; PMCID: PMC6015619.

*Acknowledgement: ClinicalTrials.gov identifier: NCT02664012. MF Stiles, LR Campbell, and T Jin are full-time employees of RAI Services Company. RAI Services Company is a wholly owned subsidiary of Reynolds American Inc., which is a wholly owned subsidiary of British American Tobacco plc. DW Graff is a full-time employee of Celerion and provided the original draft of the manuscript. RV Fant and JE Henningfield are full-time employees of PinneyAssociates, which provides consulting services on smoking cessation and tobacco harm minimization (including nicotine replacement therapy and electronic vapor products) to Niconovum, USA, Inc., RJ Reynolds Vapor Company, and RAI Services Company (all subsidiaries of Reynolds American Inc.). JE Henningfield also owns an interest in intellectual property for a novel nicotine medication. Through PinneyAssociates, Fant and Henningfield provide consulting services to pharmaceutical companies on abuse potential assessment, and the regulation of substances with a potential for abuse.

===2017 [https://pubmed.ncbi.nlm.nih.gov/28389330/ A comparison of nicotine dependence among exclusive E-cigarette and cigarette users in the PATH study]=== <!--T:18-->

<!--T:19-->

*

===2015 [https://pubmed.ncbi.nlm.nih.gov/25332459/ Development of a questionnaire for assessing dependence on electronic cigarettes among a large sample of ex-smoking E-cigarette users]=== <!--T:20-->

<!--T:21-->

*

===2015 [https://pubmed.ncbi.nlm.nih.gov/25561385/ Dependence levels in users of electronic cigarettes, nicotine gums and tobacco cigarettes]=== <!--T:22-->

<!--T:23-->

*

===2013 [https://www.federalregister.gov/documents/2013/04/02/2013-07528/modifications-to-labeling-of-nicotine-replacement-therapy-products-for-over-the-counter-human-use Modifications To Labeling of Nicotine Replacement Therapy Products for Over-the-Counter Human Use]=== <!--T:24-->

*[https://www.govinfo.gov/content/pkg/FR-2013-04-02/pdf/2013-07528.pdf PDF Version]

*Citation: Food and Drug Administration, 78 FR 19718

===2012 [https://academic.oup.com/ntr/article-abstract/14/1/75/1047894?redirectedFrom=fulltext Determinants of Tobacco Use and Renaming the FTND to the Fagerström Test for Cigarette Dependence]=== <!--T:26-->

*Citation: Karl Fagerström, Ph.D., Determinants of Tobacco Use and Renaming the FTND to the Fagerström Test for Cigarette Dependence, Nicotine & Tobacco Research, Volume 14, Issue 1, January 2012, Pages 75–78, doi: 10.1093/ntr/ntr137

*See Also: 2013: [https://nicotinepolicy.net/blogs/guest-blogs/27-karl-fagerstrom/82-dependence-on-tobacco-and-nicotine Dependence on tobacco and nicotine]

===2003 [https://pubmed.ncbi.nlm.nih.gov/12616334/ Subjective effects of the nicotine lozenge: assessment of abuse liability]=== <!--T:28-->

*Citation: Houtsmuller EJ, Henningfield JE, Stitzer ML. Subjective effects of the nicotine lozenge: assessment of abuse liability. Psychopharmacology (Berl). 2003 Apr;167(1):20-7. doi: 10.1007/s00213-002-1361-2. Epub 2003 Mar 4. PMID: 12616334.

*Acknowledgement: This research was supported by SmithKline Beecham Consumer Healthcare.

===2002 [https://pubmed.ncbi.nlm.nih.gov/12175452/ Flavor improvement does not increase abuse liability of nicotine chewing gum]=== <!--T:30-->

*Acknowledgement: This study was supported by SmithKline Beecham Consumer Healthcare.

<br>

==Addiction (Nicotine with the use or abuse of recreational substances)== <!--T:32-->